Commercial Channels

Merck’s Ervebo vaccine gets CHMP positive opinion

New player in hub services expands its call center operations

‘Global privacy regulation’ and ‘digital health’ bracket the 10 influences going into 2020

Venture is a partnership with a social-media app, Belong.Life

Analysis of its members’ covered lives show the effect of expensive specialty drugs on insurance plans

Leading pharma sampling-services company ‘recapitalizes’ with acquisition by Court Square Capital

Sponsored by McKesson

$430-million all-cash acquisition signals Veeva’s move into consumer tracking

Pushing your frontline into a new frontier

Humana repeats as top mail-order and Wegman's is best among supermarkets

New study finds a growing reliance on patient organizations for improving the patient journey

RACollab.org invites trade and channel execs to participate

Deep analysis of specialty pharmacy data shows opportunities for managing the patient journey

Emphasis is on speed to therapy

Pharmacy-level patient identification could have implications for pharma manufacturers

Appointment highlights the trend toward digital patient services

Patient support/hub services provider will build in Jeffersonville, IN

Meanwhile, federal enforcement actions over improper patient assistance continue to arise

Kalderos garners $7-million Series A funding from Mercato Partners

Latest acquisition brings commercial assets from Mission Pharmacal

Business opportunities expand, include selling healthcare data to researchers

Managed Retail Network will offer “light” patient support services through 25,000 pharmacies

Mobile apps promise to expand hub support for specialty pharmaceuticals

The Unstoppable Growth of Prescription Drug Prices

A final rule is still in the works at HHS, but some manufacturers are testing the inclusion of prices in TV ads

It takes gritty work to make an AI application succeed—but it can be worth the effort

The head of Lash Group looks at the evolving patient support / hub services environment

Hub provider and software company will partner for advancing cellular and genetic therapies (CGTs)

Model N positions itself for coming revisions in pharma trade practices